Plymouth Meeting, PA – August 3, 2015: CRF Health, the leading global provider of eCOA solutions for the life sciences industry, today announced that CEO, Rachael Wyllie, has been selected by PharmaVOICE as one of the top 100 most influential people in the life sciences industry. Rachael was recognized for her forward-thinking vision to advance the science of eCOA in clinical trials, along with her inspiring leadership in driving the creation of technologies that improve patients' lives.
The PharmaVOICE 100 celebrates those exceptional professionals in the life-sciences industry who inspire their peers, colleagues, and companies through innovation addressing the industry’s myriad of challenges.
Commenting on her achievement, Rachael said: “It’s an honor to have been recognized by PharmaVOICE among some of the industry’s leading figures. Our entire team shares a passion for the development of patient-focused and investigator-friendly eCOA technology. We work tirelessly to make this vision a reality and ensure our customers' needs are met with the highest quality solutions."
With a background in pharmaceutical research and information technology, Rachael has been innovating around the capture of patient data for over 20 years. She has been instrumental in driving CRF Health’s growth and the continued development of solutions that not only increase the quality and efficiency of clinical trials, but improve the experience for patients and caregivers globally.
For further information on CRF Health, please visit www.crfhealth.com
Share this article:
Tweet: @CRFHealth, CEO, Rachael Wyllie named in PharmaVOICE 100
Follow us on Twitter: @CRFHealth
About CRF Health
CRF Health is the leading provider of electronic Clinical Outcome Assessment (eCOA) solutions for global clinical trials. With experience in more than 545 trials, over 100 languages and across 74 countries, CRF Health’s TrialMax eCOA solutions consistently demonstrate the industry’s highest data accuracy, patient and site compliance, and patient retention.
CRF Health’s TrialMax eCOA solutions improve trial engagement by fitting into the lives of patients and seamlessly integrating into sites to maximize protocol compliance. Their eCOA solutions include PROs (Patient Reported Outcomes), ObsROs (Observer Reported Outcomes) and ClinROs (Clinician or Rater Reported Outcomes).
Contact: firstname.lastname@example.org, +1 267.498.2350